Anixa Biosciences, Inc. (ANIX)
3.48
-0.12
(-3.33%)
USD |
NASDAQ |
Aug 28, 16:00
3.59
+0.11
(+3.16%)
After-Hours: 20:00
Anixa Biosciences Cash and Short Term Investments (Quarterly) : 13.69M for April 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 13.69M |
| January 31, 2026 | 14.20M |
| October 31, 2025 | 15.17M |
| July 31, 2025 | 16.03M |
| April 30, 2025 | 15.60M |
| January 31, 2025 | 17.26M |
| October 31, 2024 | 19.92M |
| July 31, 2024 | 20.74M |
| April 30, 2024 | 23.24M |
| January 31, 2024 | 23.80M |
| October 31, 2023 | 23.84M |
| July 31, 2023 | 25.53M |
| April 30, 2023 | 26.98M |
| January 31, 2023 | 27.70M |
| October 31, 2022 | 29.69M |
| July 31, 2022 | 31.66M |
| April 30, 2022 | 32.23M |
| January 31, 2022 | 34.53M |
| October 31, 2021 | 35.73M |
| July 31, 2021 | 36.62M |
| April 30, 2021 | 38.10M |
| January 31, 2021 | 13.98M |
| October 31, 2020 | 9.057M |
| July 31, 2020 | 9.068M |
| April 30, 2020 | 5.508M |
| Date | Value |
|---|---|
| January 31, 2020 | 5.692M |
| October 31, 2019 | 5.842M |
| July 31, 2019 | 6.497M |
| April 30, 2019 | 6.572M |
| January 31, 2019 | 5.903M |
| October 31, 2018 | 5.056M |
| July 31, 2018 | 5.341M |
| April 30, 2018 | 5.422M |
| January 31, 2018 | 5.497M |
| October 31, 2017 | 6.839M |
| July 31, 2017 | 6.085M |
| April 30, 2017 | 5.127M |
| January 31, 2017 | 2.00M |
| October 31, 2016 | 3.238M |
| July 31, 2016 | 3.949M |
| April 30, 2016 | 4.762M |
| January 31, 2016 | 6.131M |
| October 31, 2015 | 6.769M |
| July 31, 2015 | 7.561M |
| April 30, 2015 | 8.480M |
| January 31, 2015 | 10.46M |
| October 31, 2014 | 5.861M |
| July 31, 2014 | 6.202M |
| April 30, 2014 | 2.668M |
| January 31, 2014 | 3.226M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |
| Sarepta Therapeutics, Inc. | 788.49M |
| Vicapsys Life Sciences, Inc. | 0.1325M |